The Matthias Samwald research group works on strategies for high-impact interventions at the interface of artificial intelligence, biomedical research and health care. Our group is part of the Institute of Artificial Intelligence at the Medical University of Vienna, Austria.
External project websites
We recently launched a prototype of the AI Strategies platform which is dedicated towards finding the most impactful and beneficial ways for utilizing AI.
We developed the Medication Safety Code platform as a simple, barrier-free and privacy-preserving solution to enable pharmacogenomics at the point-of-care.
2021–2022: netidee project “Web of AI”. Budget: 44.922 €
2021–2022: netidee project “OpenBioLink”. Budget: 44.742 €
2016–2021: Horizon 2020 project “Ubiquitous Pharmacogenomics (U-PGx): Making
actionable pharmacogenomic data and effective treatment optimization accessible to every
European citizen”. Role: Co-initiator, work package leader and executive board member. Total EU contribution 14,9 million €, budget for Medical University of Vienna: 1.429.783 €
2013-2017: FWF stand-alone project “Information technologies for clinical pharmacogenetics”, P 25608-N15. Budget: 295.942 €
Dr. med. Kathrin Blagec (senior researcher)
Dr. Adriano Barbosa da Silva (senior researcher)
Laura Franziska Graf, BSc (masters student, computer science)
Anna Breit, BSc (masters student, computer science)
Hong Xu, BSc, MSc (project assistant)
Hans Kerschbaumer (masters student, medicine)
Wolfgang Kuch (masters student, medicine)
Sebastian Hofer, MSc (PhD student)
Anna Riedl (project assistant)
Paul Schrödl, BSc (masters student, computer science)
Jose Antonio Miñarro Giménez, PhD (postdoc)
Georg Petz (external masters student, computer science)